Associate Professor Gabrielle McCallum
Principal Research Fellow and Senior Lecturer, Child and Maternal Health Division
Qualifications:
National Excellence in Education Leadership, Women in Leadership, 2017; PhD, Charles Darwin University, 2015; Masters of Public Health, Charles Darwin University, 2010; Graduate Diploma of Public Health, Charles Darwin University, 2008; Bachelor of Nursing, University of South Australia, 1998
Approved level of HDR supervision at Charles Darwin University:
Primary Supervisor
Location:
Darwin - Royal Darwin Hospital campus
Biography:
A/Prof Gabrielle McCallum is a Senior Research Fellow and Senior Lecturer, Nurse academic, and Program Leader of Menzies’ Child Health Respiratory team in Darwin. Having worked in the Northern Territory for over two decades, Gabrielle’s passion is to improve clinical outcomes for children at-risk for poor lung health outcome, through preventing early and recurrent acute lower respiratory infections, evidence-based research, culturally appropriate educational resources, and translating research findings into meaningful and culturally appropriate outcomes.
Gabrielle’s work includes multiple large, NHMRC-funded multi-centre randomised controlled trials and other observational studies with a multidisciplinary team, extending nationally and internationally to New Zealand, Alaska, Malaysia, and Timor-Leste.
A/Prof McCallum’s novel randomised controlled trials, and follow-up studies, are the world’s first trials on bronchiolitis in First Nations children. Her outcomes have been translated into changes for health policy to improve follow-up post-hospitalisation for bronchiolitis and directly into national and international bronchiolitis treatment guidelines. Her research has led to a paradigm shift in paediatric respiratory management of bronchiolitis across the Northern Territory.
A/Prof McCallum’s passion for improving respiratory education led to developing and evaluating the first, First-Nations-specific educational flipcharts for common childhood respiratory conditions (bronchiolitis, pneumonia, bronchiectasis and asthma) that have been adapted to a multi-lingual mobile application “Lung Health for Kids”.
Research Themes
- Child and Maternal Health
- Respiratory Health
- Preventing recurrent ALRIs (PETAL) study: a multi-centre randomised controlled trial
- Bronchiectasis Action Management Plan (BAMP) Study: a multi-centre randomised controlled trial
- Bronchiectasis App evaluation
- LOng Term follow Up improves clinical care and respiratory outcomeS for Indigenous children (LOTUS) Study
- Transition from paediatric to adult medical care with bronchiectasis (TRACE Study)
- Hospitalised Pneumonnia with Extension Treatment study (HOPE): a multi-centre randomised controlled trial
- Short and long-term effects of therapeutic exercise in children with bronchiectasis: a multi-centre randomised controlled trial (BREATH)
- The Patho-micro-biology of protracted bacterial bronchitis and chronic suppurative lung disease in children
- Australian Bronchiectasis Registry
- Prophylactic antibiotics to prevent chest infections in children with neurological impairment (PARROT) study: a multi-centre randomised controlled trial
- Reducing Exacerbations in People with PCD using Erdosteine and Azithromycin Therapy (REPEAT): a multi-centre randomised controlled trial
- Preventing early-onset pneumonia in high-risk children through maternal immunization (Pneumatters): a multi-centre randomised controlled trial
- Aboriginal and Torres Strait Islander Partnerships to Prevent Permanent Disease (APPLE Study)
- Oral bacterial lysate to prevent persistent wheeze in infants after severe bronchiolitis; a randomised placebo-controlled trial (BLIPA-AUS)
- Bronchiectasis Trial Testing Erdosteine (BETTER) Study
- Respiratory service-item evaluation (RESET) study
- Development and internal validation of the paediatric pneumonia severity (PEPS) score
- Graduated Compression Stockings for DVT Prophylaxis: A Risk Benefit Analysis (SPARK Study)
- Respectful maternity care and the association with child health outcomes
- McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH, Nachiappan N, Saari N, Morris PS, Yeo TW, Ware RS, Elogius BW, Oguoma VM, Yerkovich ST, de Bruyne J, Lawrence KA, Lee B, Upham JW, Torzillo PJ, Chang AB. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial. Pediatr Infect Dis J. 2022 Jul 1;41:549-555. Epub 2022 Jun 7. PMID: 35476706.
- McCallum GB, Morris PS, Grimwood K, Maclennan C, White AV, Chatfield MD, Sloots TP, Mackay IM, Smith-Vaughan H, Mckay CC, Versteegh LA, Jacobsen N, Mobberley C, Byrnes CA, Chang AB. Three-weekly doses of azithromycin for Indigenous infants hospitalised with bronchiolitis: A multi-centre, randomised, placebo-controlled trial. Front Pediatr 2015;3.
- McCallum GB, Chatfield MD, Morris PS, Chang AB. Risk factors for adverse outcomes of Indigenous infants hospitalised with bronchiolitis. Pediatr Pulmonol 2016;51:613-23.
- McCallum GB, Plumb EJ, Morris PS, Chang AB. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. Cochrane Database Syst Rev 2017;8:CD009834.
- Singleton RJ, Valery PC, Morris PS, Byrnes CA, Grimwood K, Redding G, Torzillo PJ, McCallum GB, Chikoyak L, Mobberley C, Holman RC, Chang AB. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol 2014;49:189-200.
- Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 2013;8:610-20.
- McCallum GB, Binks MJ. The epidemiology of chronic suppurative lung disease and bronchiectasis in children and adolescents. Front Pediatr 2017;5.
- McCallum GB, Singleton RJ, Redding GJ, Grimwood K, Byrnes CA, Valery PC, Mobberley C, Oguoma VM, Eg KP, Morris PS, Chang AB. A decade on: Follow-up findings of Indigenous children with bronchiectasis. Pediatric Pulmonol 2020 55:975-85.
- McCallum GB, Oguoma VM, Versteegh LA, Wilson CA, Bauert P, Spain B, Chang AB. Comparison of Profiles of First Nations and non-First Nations children with bronchiectasis over two 5-Year periods in the Northern Territory, Australia. Chest 2021 Oct;160:1200-1210.
- Chang AB, Normansell R, Griwmood K, Alexopoulou E, Bell L, Boyd J, Bush A, Chalmers JD, Hill AT, Karadag B, Midulla F, McCallum GB, Powell Z, Snijders D, Song WJ, Tonia T, Wilson C, Zacharasiewicz A, Kantar A. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J 2021 Aug 26;58:2002990.
Read more at https://pubmed.ncbi.nlm.nih.gov/?term=mccallum%20GB&sort=date&pos=5
